A drug production device includes a plurality of drug containers, coupled to a drug dispensing channel.

The present invention also relates to the manufacture of a medicament for the treatment of endothelial dysfunction.

It is intended to provide a novel process for producing soyasapogenol B which is useful as a drug or a material for producing drugs.

a discontinuation of a drug six months in advance; and

Medicinal drug manufacturing is unequally distributed throughout the world.

The cluster represents 50% of drug production in France and 30,000 jobs.

The cluster represents 50% of drug production in France and 30,000 jobs.

The invention further relates to compounds of general formula (I) as a medicament and to the use of said compounds for producing drugs for hormone replacement therapy.

The present invention describes the use of Notch2 inhibitors for producing a medicament for the treatment of tumours, which tumours are characterised by ligand-independent Notch2 fragments.

A practical process by which an α,ß,Ϝ-substituted cyclopentanone derivative which is useful as a medicine or an intermediate for medicine production is more efficiently and safely produced than known techniques.

A drug production device includes a plurality of drug containers, coupled to a drug dispensing channel.

According to the inventive method for producing a medicament, powder is introduced into a press mould (10), the powder is pressed and the moulding is then removed from the press mould.

The invention also relates to a method for producing said drug.

The present patent application refers to a process for production of a drug carrier, the drug itself and its usage.

Use of the interferon for the manufacture of an appropriate medicament is disclosed.